4//SEC Filing
PROGENICS PHARMACEUTICALS INC 4
Accession 0001447348-14-000036
CIK 0000835887operating
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 11:27 AM ET
Size
8.3 KB
Accession
0001447348-14-000036
Insider Transaction Report
Form 4
ISRAEL ROBERT J
Sr. VP, Medical Affairs
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2014-12-11$7.07/sh−3,000$21,201→ 18,000 totalExercise: $5.35From: 2011-07-01Exp: 2020-07-01→ Common Stock (3,000 underlying) - Sale
Common Stock
2014-12-11$7.07/sh−3,000$21,201→ 35,050 total - Exercise/Conversion
Common Stock
2014-12-11$5.35/sh+3,000$16,050→ 38,050 total
Footnotes (2)
- [F1]The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer.
- [F2]The stock options become exercisable in three equal annual installments, commencing one year from the grant date.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000835887
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 11:27 AM ET
- Size
- 8.3 KB